FLASH NEWS
Pharmaceutical products do not recognize a consumption crisis, imports increase annually by 17% in 8 months
2023-09-21 08:15:26 / EKONOMI&SOCIALE
Population reduction is causing imports to decline in some categories such as cereals and sugars, but imports of pharmaceutical products in volume increased by 17% in January-August 2023.
INSTAT data show that imports of pharmaceutical products in quantity reached 4,400 tons in the reference period from 3,800 tons in 2022, but in terms of value they decreased by about 1%. This trend indicates an increase in the amount of imported pharmaceutical products, but at a lower price.
Pharmaceutical market experts explain that the value of imports has decreased, as vaccines and antibiotics against Covid-19 have been reduced, increasing the value of imports during 2021 and 2023 (see chart below).
The expansion of import volumes for pharmaceutical products is being driven by increased consumption due to an aging population and increased disease burden. But on the other hand, the scope for further growth of imports in pharmaceutical articles is high because Albanians have the weakest per capita consumption of pharmaceutical products in relation to Europe and the countries of the region.
More detailed data show that Albanians have low access to the main drugs that treat diseases, cardiovascular, oncology, autoimmune, nervous, etc.
Psh barnat e reja që kanë një trend të lartë shitje në tregjet europiane dhe ato të rajonit ende nuk janë futur në tregun shqiptar. Ato kushtojnë shumë dhe nuk janë të përballueshme për pacientët, pasi shteti nuk i rimburson. P.sh. në Shqipëri nuk janë të pranishme te tilla Apixaban, Pembrolizumab që trajtojnë sëmundje autoimune.
Tregu shqiptar është në zhvillim e sipër, ku barnat tradicionale gjenerike dhe ato jashtë patentës përfaqësojnë 76%, ndërsa trajtimi spitalor i specializuar dhe me terapi inovative vetëm 24%.
Përfaqësuesit e tregut farmaceutik bëjnë me dije se nevojat e popullsisë janë shumë më të larta se furnizimet aktuale. Po përvoja globale ka treguar se financimet publike dhe orientimi i tyre i drejtë i çon përpara sistemet shëndetësore dhe përmirëson ndjeshëm shërbimet shëndetësore për popullatën.
Low budget funding has led to low reimbursement of innovative medications that cure diseases such as cancer and autoimmune diseases.
Budgetary funds for the reimbursement of medications have remained at the level of 10-11 billion ALL for years, even though the needs of the aging population are increasing.
The stagnation of reimbursement funds also keeps the drug market underdeveloped and biases it toward cheaper products. /MONITOR
Happening now...
83 mandates are not immunity for Rama's friends
Nga Gentian Gaba
ideas
"Preliminary sentence for Belinda Balluku", response to Baton Haxhiu
Nga Blendi Kajsiu
Teatri që fsheh prapaskenën
Nga Patrik Sadikaj
Berisha's red line and the black line of democracy in the DP
Besmir Semanaj
top
Alfa recipes
TRENDING 
services
- POLICE129
- STREET POLICE126
- AMBULANCE112
- FIREFIGHTER128